Wim L.J. van Putten

Dose-Response in Radiotherapy for Localized Prostate Cancer: Results of the Dutch Multicenter Randomized Phase III Trial Comparing 68 Gy of Radiotherapy With 78 Gy

Stéphanie Peeters, Wilma D. Heemsbergen, P. Koper et al. · Journal of Clinical Oncology · 2006 · 977 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Pooled Analysis of Prognostic Impact of Urokinase-Type Plasminogen Activator and Its Inhibitor PAI-1 in 8377 Breast Cancer Patients

Maxime P. Look, Wim L.J. van Putten, Michael J. Duffy et al. · JNCI Journal of the National Cancer Institute · 2002 · 604 citations · Full text

Medicine, Biostatistics, Oncology +15

Monosomal Karyotype in Acute Myeloid Leukemia: A Better Indicator of Poor Prognosis Than a Complex Karyotype

Dimitri Breems, Wim L.J. van Putten, Georgine E. de Greef et al. · Journal of Clinical Oncology · 2008 · 577 citations · Full text

Life Sciences, Hematology, Oncology +17

Double CEBPA mutations, but not single CEBPA mutations, define a subgroup of acute myeloid leukemia with a distinctive gene expression profile that is uniquely associated with a favorable outcome

Bas J. Wouters, Bob Löwenberg, Claudia Erpelinck-Verschueren et al. · Blood · 2009 · 572 citations · Full text

Life Sciences, Genetics, Oncology +14

Prognostic Index for Adult Patients With Acute Myeloid Leukemia in First Relapse

Dimitri Breems, Wim L.J. van Putten, Peter C. Huijgens et al. · Journal of Clinical Oncology · 2005 · 515 citations

Medicine, Hematology, Oncology +17